Mass. lawmakers see support for $1B biotech bill

One of the top lawmakers in Massachusetts is predicting swift passage of a new bill that would provide a billion dollars in incentives to the life sciences industry in the state. The area around Boston is one of the biggest hubs of biotechnology in the world, but Governor Deval Patrick believes that these incentives--including $500 million for new equipment--is needed to safeguard Massachusetts from predators of the economic development world. A host of states--and several countries--have been designing incentives for biotech companies and the research groups that spawn new development projects. The state has done little, until now, to actually support biotech.

- read the report for more

Suggested Articles

Paragon Biosciences has hired Kerensa Jimenez as the new CEO of its capital markets group Paragon Health Capital.

Regeneron has taken a step closer to getting a green light for its experimental high cholesterol drug as the FDA allows a swift review of evicanumab.

An analysis of Gilead’s remdesivir clinical trials found the studies “failed to provide equal representation of Black, Latinx and Native Americas."